Continued studies are essential to fully understand its therapeutic potential and safety profile, paving the way for potential clinical applications in managing metabolic diseases
GLP-1 receptor agonists, such as semaglutide and liraglutide, are increasingly prescribed in the UK for type 2 diabetes and weight management
Patients with pre-existing conditions including cardiovascular disease, liver disease, thyroid disorders, kidney disease, or gallbladder disease face particular uncertainty
Does KLOW improve hair or nails
As a significant gut hormone, PYY is receiving attention in the treatment strategies of obesity and other metabolic disorders, particularly in combination therapies with other incretins
Hsieh TYJ, Lu C, Lee G-Y, Wei JC-C